Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00227201
Recruitment Status : Completed
First Posted : September 27, 2005
Last Update Posted : April 25, 2008
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
Weill Medical College of Cornell University

Tracking Information
First Submitted Date September 23, 2005
First Posted Date September 27, 2005
Last Update Posted Date April 25, 2008
Study Start Date June 2003
Primary Completion Date Not Provided
Current Primary Outcome Measures
 (submitted: April 23, 2008)
The impact of positive affect induction and self-affirmation on medication adherence and blood pressure control.
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT00227201 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Outcome Measures Not Provided
Original Other Outcome Measures Not Provided
 
Descriptive Information
Brief Title The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans
Official Title The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans
Brief Summary The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure.
Detailed Description The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure. Through the use of qualitative interviews, the beliefs and attitudes toward complementary medicine of African Americans with hypertension will be elucidated.
Study Type Observational
Study Design Not Provided
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Not Provided
Study Population Not Provided
Condition Hypertension
Intervention Behavioral: Self-affirmation intervention
Study Groups/Cohorts Not Provided
Publications * JA Moore, Factors that influenced medication adherence among African-Americans with hypertension, to be presented at the 12th Annual NHLBI Cardiovascular Minority Research Supplement Awardee Session, American Heart Association, November 2004.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Enrollment
 (submitted: September 26, 2005)
60
Original Enrollment Same as current
Study Completion Date May 2005
Primary Completion Date Not Provided
Eligibility Criteria

Inclusion Criteria:

  1. Patients will be African-American adults 18 years or older who were diagnosed with poorly controlled hypertension as defined by the 6th Joint National Committee guidelines (systolic >140 and diastolic >90).
  2. Patients will also be eligible if they are taking any prescribed anti-hypertensive medications.
  3. Patients must be able to provide informed consent in English. Participants will be recruited from Cornell Internal Medicine Associates, the primary care and general medicine practice at Cornell Medical Center, the same site as the parent grant.

Exclusion Criteria:

  1. Patients who refused to participate.
  2. Patients who are unable to provide informed consent.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00227201
Other Study ID Numbers 0301005948
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Not Provided
Study Sponsor Weill Medical College of Cornell University
Collaborators National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Jason Moore Weill Medical College of Cornell University
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
PRS Account Weill Medical College of Cornell University
Verification Date April 2008